Nkarta shares get price target boost at Canaccord on autoimmune focus By Investing.com

Published on 26 Mar 2024 on Investing.com

Tuesday, Canaccord Genuity (TSX:CF) maintained a Buy rating on Nkarta Inc. (NASDAQ:NKTX) and...

Read the rest of the article

Start tracking your investments with Statfolio

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month Benzinga and Yahoo Finance ...

Benzinga · via Yahoo Finance 8 Oct 2024

Tuesday, Canaccord Genuity (TSX:CF) maintained a Buy rating on Nkarta Inc. (NASDAQ:NKTX) and...

Investing.com 26 Mar 2024

Shares of Landos Biopharma, Inc. LABP rose sharply during Monday’s session following acquisition...

Benzinga 25 Mar 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on M...

Benzinga 25 Mar 2024

Nkarta sets $10 per share in $240 million stock offering

Investing.com 25 Mar 2024

Shares of Cutera, Inc. CUTR fell sharply during Friday’s session after the company reported wors...

Benzinga 22 Mar 2024

Stocks slightly retreated during New York’s morning session on Friday, following another robust w...

Benzinga 22 Mar 2024

Thursday, in its fourth quarter 2023 earnings release, Nkarta Inc NKTX said it closed patient enr...

Benzinga 22 Mar 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 22 Mar 2024

Nkarta, Inc. NKTX posted a loss for the fourth quarter on Thursday. The company posted a quarter...

Benzinga 22 Mar 2024